Human papillomavirus infection and bladder cancer risk: A meta-analysis

Journal of Infectious Diseases

Volumn 204, Issue 2, 2011, Pages 217-223

  Li, Ni ^a   Yang, Lin ^a   Zhang, Yawei ^b   Zhao, Ping ^a   Zheng, Tongzhang ^b   Dai, Min ^a  

^a CANCER HOSPITAL   (China)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VIRUS DETECTION; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS;

EID: 79958748194     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir248     Document Type: Article

References (46)

1. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19:1-5.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90. Geneva: WHO Press, 2007.
3. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat 2011; 126:515-20.
4. Iwasawa A, Kumamoto Y, Maruta H, et al. Presence of human papillomavirus 6/11 DNA in condyloma acuminatum of the urinary bladder. Urol Int 1992; 48:235-8.
5. Karim RZ, Rose BR, Brammah S, Scolyer RA. Condylomata acuminata of the urinary bladder with HPV 11. Pathology 2005; 37:176-8. (Pubitemid 40593414)
6. Lopez-Beltran A,Munoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 1995; 26:565-9.
7. Badawi H, Ahmed H, Ismail A, et al. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med 2008; 10:232.
8. Lopez-Beltran A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L. Human papillomavirus infection and transitional cell carcinoma of the bladder: immunohistochemistry and in situ hybridization. Pathol Res Pract 1996; 192:154-9. (Pubitemid 26104328)
9. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998; 159:86-9. (Pubitemid 127739878)
10. Youshya S, Purdie K, Breuer J, et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 2005; 58:207-10. (Pubitemid 40193809)
11. Cooper K, Haffajee Z, Taylor L. Human papillomavirus and schistosomiasis associated bladder cancer. Mol Pathol 1997; 50:145-8. (Pubitemid 27454999)
12. Knowles MA. Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res 1992; 20:297-301.
13. Smetana Z, Keller T, Leventon-Kriss S, et al. Presence of human papilloma virus in transitional cell carcinoma in Jewish population in Israel. Cell Mol Biol (Noisy-le-grand) 1995; 41:1017-23.
14. Chang F, Lipponen P, Tervahauta A, Syrjanen S, Syrjanen K. Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridization and polymerase chain reaction. J Urol 1994; 152:1429-33. (Pubitemid 24326277)
15. Sano T, Sakurai S, Fukuda T, Nakajima T. Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol Int 1995; 45:506-12.
16. Sur M, Cooper K, Allard U. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa. Pathology 2001; 33:17-20. (Pubitemid 32222504)
17. Gopalkrishna V, Srivastava AN, Hedau S, Sharma JK, Das BC. Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction. Genitourin Med 1995; 71:231-3.
18. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009; 1:4-8.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-48.
20. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007; 28:105-14. (Pubitemid 44937874)
21. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34. (Pubitemid 27387172)
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-101.
23. Bryant P, Davies P, Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol 1991; 68:49-52.
24. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis 2005; 5:102-106.
25. Fioriti D, Pietropaolo V, Dal FS, Laurenti C, Chiarini F, Degener AM. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003; 16:283-8. (Pubitemid 39011236)
26. LaRue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res 1995; 1:435-40.
27. Ludwig M, Kochel HG, Fischer C, Ringert RH, Weidner W. Human papillomavirus in tissue of bladder and bladder carcinoma specimens: a preliminary study. Eur Urol 1996; 30:96-102.
28. Noel JC, Thiry L, Verhest A, et al. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 1994; 44:671-5.
29. Tekin MI, Tuncer S, Aki FT, Bilen CY, Aygun C, Ozen H. Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction. Int J Urol 1999; 6:184-6. (Pubitemid 30406840)
30. Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 1992; 70:1967-73.
31. Agliano AM, Gradilone A, Gazzaniga P, et al. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 1994; 53:125-9. (Pubitemid 24329430)
32. Escudero AL, Luque RJ, Quintero A, et al. Association of human herpesvirus type 6 DNA with human bladder cancer. Cancer Lett 2005; 230:20-4. (Pubitemid 41506956)
33. Yu ST, Wu MM, Li LM. Prevalence of human papillomaviruses 16 and 18 in transitional cell carcinoma of bladder. Chin Med J (Engl) 1993; 106:494-6.
34. Chan KW, Wong KY, Srivastava G. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol 1997; 50:1018-21. (Pubitemid 28055629)
35. Chetsanga C, Malmstrom PU, Gyllensten U, Moreno-Lopez J, Dinter Z, Pettersson U. Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer 1992; 69:1208-11.
36. Kerley SW, Persons DL, Fishback JL. Human papillomavirus and carcinoma of the urinary bladder. Mod Pathol 1991; 4:316-9.
37. Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR. Human papillomavirus associated with bladder cancer. Urology 1992; 40:15-7.
38. Gazzaniga P, Vercillo R, Gradilone A, et al. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 1998; 55:262-7. (Pubitemid 28302479)
39. Gould VE, Schmitt M, Vinokurova S, et al. Human papillomavirus and p16 expression in inverted papillomas of the urinary bladder. Cancer Lett 2010; 292:171-5.
40. Gutierrez J, Jimenez A, de Dios LJ, Soto MJ, Sorlozano A. Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J Urol 2006; 176:2474-81. (Pubitemid 44665953)
41. Wiwanitkit V. Urinary bladder carcinoma and human papilloma virus infection, an appraisal of risk. Asian Pac J Cancer Prev 2005; 6:217-8.
42. de Sanjosé S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7:453-9. (Pubitemid 46962343)
43. SrinivasanM, Taioli E, Ragin CC. Human papillomavirus type 16 and 18 in primary lung cancers - a meta-analysis. Carcinogenesis 2009; 30:1722-8.
44. Khaled HM, Bahnassi AA, Zekri AR, Kassem HA, Mokhtar N. Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol 2003; 21:334-41. (Pubitemid 38534172)
45. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31:259-66. (Pubitemid 44141088)
46. Taylor ML, Mainous AG III, Wells BJ. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 2005; 37:506-12. (Pubitemid 40967713)